About: Glucosamine

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Glucosamine Goto Sponge NotDistinct Permalink

An Entity of Type : http://linked.opendata.cz/ontology/drugbank/Drug, within Data Space : linked.opendata.cz associated with source document(s)

Attributes	Values
rdf:type	http://linked.opendata.cz/ontology/drugbank/Drug
http://linked.open...gbank/description	Glucosamine is commonly used as a treatment for osteoarthritis, although its acceptance as a medical therapy varies. It is an amino sugar and a prominent precursor in the biochemical synthesis of glycosylated proteins and lipids. Since glucosamine is a precursor for glycosaminoglycans, and glycosaminoglycans are a major component of joint cartilage, supplemental glucosamine may help to rebuild cartilage and treat arthritis. (en)
http://linked.open...generalReferences	# Towheed TE, Maxwell L, Anastassiades TP, Shea B, Houpt J, Robinson V, Hochberg MC, Wells G: Glucosamine therapy for treating osteoarthritis. Cochrane Database Syst Rev. 2005 Apr 18;(2):CD002946. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/15846645 # Roseman S: Reflections on glycobiology. J Biol Chem. 2001 Nov 9;276(45):41527-42. Epub 2001 Sep 11. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/11553646 # GHOSH S, BLUMENTHAL HJ, DAVIDSON E, ROSEMAN S: Glucosamine metabolism. V. Enzymatic synthesis of glucosamine 6-phosphate. J Biol Chem. 1960 May;235:1265-73. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/13827775 # Buse MG: Hexosamines, insulin resistance, and the complications of diabetes: current status. Am J Physiol Endocrinol Metab. 2006 Jan;290(1):E1-E8. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/16339923 # Laverty S, Sandy JD, Celeste C, Vachon P, Marier JF, Plaas AH: Synovial fluid levels and serum pharmacokinetics in a large animal model following treatment with oral glucosamine at clinically relevant doses. Arthritis Rheum. 2005 Jan;52(1):181-91. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/15641100 # Lexicomp [Internet]. Glucosamine (Natural Products Database). 2014. Available from: http://online.lexi.com.login.ezproxy.library.ualberta.ca/lco/action/doc/retrieve/docid/fc_rnp2/3750166# (en)
http://linked.open...gy/drugbank/group	approved (en)
http://linked.open...ugbank/indication	Glucosamine is usually used in the treatment of osteoarthritis, although its efficacy is still in question. (en)
sameAs	Glucosamine
Title	Glucosamine (en)
adms:identifier	http://linked.opendata.cz/resource/drugbank/drug/DB01296/identifier/chebi/5417 http://linked.opendata.cz/resource/drugbank/drug/DB01296/identifier/chemspider/388352 http://linked.opendata.cz/resource/drugbank/drug/DB01296/identifier/drugbank/DB01296 http://linked.opendata.cz/resource/drugbank/drug/DB01296/identifier/pubchem-compound/439213 http://linked.opendata.cz/resource/drugbank/drug/DB01296/identifier/pubchem-substance/46506420 http://linked.opendata.cz/resource/drugbank/drug/DB01296/identifier/pharmgkb/PA164747613 http://linked.opendata.cz/resource/drugbank/drug/DB01296/identifier/wikipedia/Glucosamine
http://linked.open...mechanismOfAction	Glucosamine is an amino sugar and a prominent precursor in the biochemical synthesis of glycosylated proteins and lipids. Oral glucosamine is commonly used for the treatment of osteoarthritis. Since glucosamine is a precursor for glycosaminoglycans, and glycosaminoglycans are a major component of joint cartilage, supplemental glucosamine may help to rebuild cartilage and treat arthritis. Its use as a therapy for osteoarthritis appears safe, but there is conflicting evidence as to its effectiveness with more recent studies showing limited to no clinical benefit of use. In the United States, glucosamine is not approved by the Food and Drug Administration for medical use in humans. Since glucosamine is classified as a dietary supplement, safety and formulation are solely the responsibility of the manufacturer; evidence of safety and efficacy is not required as long as it is not advertised as a treatment for a medical condition. (en)
http://linked.open...drugbank/packager	21st Century Healthcare Inc. Equaline Vitamins Freeda Vitamins Pharmaceutical Utilization Management Program VA Inc. APP Pharmaceuticals APPD Baxter International Inc. Bedford Labs Ben Venue Laboratories Inc. Bristol-Myers Squibb Co. Mead Johnson and Co. Pharmachemie BV
http://linked.open.../drugbank/synonym	2-Amino-2-deoxy-D-glucose (en) Chitosamine (en) D-Glucosamine (en)
http://linked.open...drugbank/toxicity	Adverse effects are generally mild: itching, diarrhea, heartburn, nausea and vomiting. (en)
http://linked.open...ynthesisReference	Yuichi Yamamura, Ichiro Azuma, Shigeru Kobayashi, "Glucosamine peptide derivatives, their production and use." U.S. Patent US4369178, issued July, 1978. (en)
foaf:page	http://www.drugs.com/cdi/glucosamine.html
http://linked.open...ugbank/IUPAC-Name	http://linked.opendata.cz/resource/drugbank/property/271B63E7-363D-11E5-9242-09173F13E4C5
http://linked.open...gy/drugbank/InChI	http://linked.opendata.cz/resource/drugbank/property/271B63ED-363D-11E5-9242-09173F13E4C5
http://linked.open...Molecular-Formula	http://linked.opendata.cz/resource/drugbank/property/271B63EC-363D-11E5-9242-09173F13E4C5
http://linked.open.../Molecular-Weight	http://linked.opendata.cz/resource/drugbank/property/271B63E9-363D-11E5-9242-09173F13E4C5
http://linked.open...noisotopic-Weight	http://linked.opendata.cz/resource/drugbank/property/271B63EA-363D-11E5-9242-09173F13E4C5
http://linked.open...y/drugbank/SMILES	http://linked.opendata.cz/resource/drugbank/property/271B63EB-363D-11E5-9242-09173F13E4C5
http://linked.open.../Water-Solubility	http://linked.opendata.cz/resource/drugbank/property/271B63E5-363D-11E5-9242-09173F13E4C5
http://linked.open...ogy/drugbank/logP	http://linked.opendata.cz/resource/drugbank/property/271B63E3-363D-11E5-9242-09173F13E4C5 http://linked.opendata.cz/resource/drugbank/property/271B63E6-363D-11E5-9242-09173F13E4C5
http://linked.open...ogy/drugbank/logS	http://linked.opendata.cz/resource/drugbank/property/271B63E4-363D-11E5-9242-09173F13E4C5
http://linked.open...l/drug/hasATCCode	Glucosamine
http://linked.open...nd-Acceptor-Count	http://linked.opendata.cz/resource/drugbank/property/271B63F3-363D-11E5-9242-09173F13E4C5
http://linked.open...-Bond-Donor-Count	http://linked.opendata.cz/resource/drugbank/property/271B63F4-363D-11E5-9242-09173F13E4C5
http://linked.open...drugbank/InChIKey	http://linked.opendata.cz/resource/drugbank/property/271B63EE-363D-11E5-9242-09173F13E4C5
http://linked.open...urface-Area--PSA-	http://linked.opendata.cz/resource/drugbank/property/271B63EF-363D-11E5-9242-09173F13E4C5
http://linked.open...nk/Polarizability	http://linked.opendata.cz/resource/drugbank/property/271B63F1-363D-11E5-9242-09173F13E4C5
http://linked.open...bank/Refractivity	http://linked.opendata.cz/resource/drugbank/property/271B63F0-363D-11E5-9242-09173F13E4C5
http://linked.open...atable-Bond-Count	http://linked.opendata.cz/resource/drugbank/property/271B63F2-363D-11E5-9242-09173F13E4C5
http://linked.open.../affectedOrganism	Humans and other mammals (en)
http://linked.open...casRegistryNumber	3416-24-8 (en)
http://linked.open...gbank/containedIn	Cisplatin 1 mg/ml vial Glucosamine hcl (d) powder Glucosamine 750 mg caplet Glucosamine relief 1000 mg tablet Glucosamine 500 mg caplet Glucosamine sulf 750 mg cplt Eql glucosamine 1000 mg tablet Sm glucosamine hcl 1500 mg tablet Glucosamine 500 mg tablet Cidatrine 500 mg tablet
http://linked.open...k/Bioavailability	http://linked.opendata.cz/resource/drugbank/property/271B63F9-363D-11E5-9242-09173F13E4C5
http://linked.open...bank/Ghose-Filter	http://linked.opendata.cz/resource/drugbank/property/271B63FB-363D-11E5-9242-09173F13E4C5
http://linked.open...nk/MDDR-Like-Rule	http://linked.opendata.cz/resource/drugbank/property/271B63FC-363D-11E5-9242-09173F13E4C5
http://linked.open...ank/Melting-Point	http://linked.opendata.cz/resource/drugbank/property/271B63FD-363D-11E5-9242-09173F13E4C5
http://linked.open...k/Number-of-Rings	http://linked.opendata.cz/resource/drugbank/property/271B63F8-363D-11E5-9242-09173F13E4C5
http://linked.open...siological-Charge	http://linked.opendata.cz/resource/drugbank/property/271B63F7-363D-11E5-9242-09173F13E4C5
http://linked.open...bank/Rule-of-Five	http://linked.opendata.cz/resource/drugbank/property/271B63FA-363D-11E5-9242-09173F13E4C5
http://linked.open...tional-IUPAC-Name	http://linked.opendata.cz/resource/drugbank/property/271B63E8-363D-11E5-9242-09173F13E4C5
http://linked.open...strongest-acidic-	http://linked.opendata.cz/resource/drugbank/property/271B63F5-363D-11E5-9242-09173F13E4C5
http://linked.open...-strongest-basic-	http://linked.opendata.cz/resource/drugbank/property/271B63F6-363D-11E5-9242-09173F13E4C5

Faceted Search & Find service v1.16.118 as of Jun 21 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 46 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software